• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷帕霉素与长寿:观点文章

Rapamycin for longevity: opinion article.

作者信息

Blagosklonny Mikhail V

机构信息

Cell Stress Biology Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

出版信息

Aging (Albany NY). 2019 Oct 4;11(19):8048-8067. doi: 10.18632/aging.102355.

DOI:10.18632/aging.102355
PMID:31586989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6814615/
Abstract

From the dawn of civilization, humanity has dreamed of immortality. So why didn't the discovery of the anti-aging properties of mTOR inhibitors change the world forever? I will discuss several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today. Furthermore, the alternative to the reversible (and avoidable) side effects of rapamycin/everolimus are the irreversible (and inevitable) effects of aging: cancer, stroke, infarction, blindness and premature death. I will also discuss why it is more dangerous not to use anti-aging drugs than to use them and how rapamycin-based drug combinations have already been implemented for potential life extension in humans. If you read this article from the very beginning to its end, you may realize that the time is now.

摘要

自文明伊始,人类就一直梦想着长生不老。那么,为什么mTOR抑制剂抗衰老特性的发现没有永远改变世界呢?我将探讨几个原因,包括对雷帕霉素、依维莫司和其他临床批准药物的实际及虚构副作用的担忧,并认为目前并没有真正的副作用会妨碍它们用作抗衰老药物。此外,与雷帕霉素/依维莫司可逆(且可避免)的副作用相比,衰老带来的是不可逆(且不可避免)的影响:癌症、中风、梗死、失明和过早死亡。我还将讨论为什么不使用抗衰老药物比使用它们更危险,以及基于雷帕霉素的药物组合如何已被用于人类潜在的寿命延长。如果你从头到尾读完这篇文章,你可能会意识到现在就是时机。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b201/6814615/40e971a0d068/aging-11-102355-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b201/6814615/49fdf79a3c1e/aging-11-102355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b201/6814615/f07eec68c9fc/aging-11-102355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b201/6814615/40e971a0d068/aging-11-102355-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b201/6814615/49fdf79a3c1e/aging-11-102355-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b201/6814615/f07eec68c9fc/aging-11-102355-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b201/6814615/40e971a0d068/aging-11-102355-g003.jpg

相似文献

1
Rapamycin for longevity: opinion article.雷帕霉素与长寿:观点文章
Aging (Albany NY). 2019 Oct 4;11(19):8048-8067. doi: 10.18632/aging.102355.
2
Rejuvenating immunity: "anti-aging drug today" eight years later.恢复活力的免疫力:八年后的“今日抗衰老药物”
Oncotarget. 2015 Aug 14;6(23):19405-12. doi: 10.18632/oncotarget.3740.
3
From rapalogs to anti-aging formula.从雷帕霉素类似物到抗衰老配方。
Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033.
4
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond.雷帕霉素作用机制靶点(mTOR)的抑制——雷帕霉素及其他。
Cold Spring Harb Perspect Med. 2016 May 2;6(5):a025924. doi: 10.1101/cshperspect.a025924.
5
Why Is Rapamycin Not a Rapalog?雷帕霉素为什么不是雷帕霉素类似物?
Gerontology. 2023;69(6):657-659. doi: 10.1159/000528985. Epub 2023 Jan 7.
6
Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.雷帕霉素:一种源自复活节岛土壤的衰老抑制剂。
J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):841-9. doi: 10.1093/gerona/glw090. Epub 2016 May 21.
7
An anti-aging drug today: from senescence-promoting genes to anti-aging pill.当下的一种抗衰老药物:从促衰老基因到抗衰老药丸。
Drug Discov Today. 2007 Mar;12(5-6):218-24. doi: 10.1016/j.drudis.2007.01.004. Epub 2007 Feb 9.
8
How to save Medicare: the anti-aging remedy.如何拯救医疗保险:抗衰老疗法。
Aging (Albany NY). 2012 Aug;4(8):547-52. doi: 10.18632/aging.100479.
9
Rapamycin extends life- and health span because it slows aging.雷帕霉素可延长寿命和健康期,因为它能延缓衰老。
Aging (Albany NY). 2013 Aug;5(8):592-8. doi: 10.18632/aging.100591.
10
Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.衰老与不朽:准程序性衰老及其药物抑制
Cell Cycle. 2006 Sep;5(18):2087-102. doi: 10.4161/cc.5.18.3288. Epub 2006 Sep 15.

引用本文的文献

1
Targeting Dermal Fibroblast Senescence: From Cellular Plasticity to Anti-Aging Therapies.靶向真皮成纤维细胞衰老:从细胞可塑性到抗衰疗法
Biomedicines. 2025 Aug 7;13(8):1927. doi: 10.3390/biomedicines13081927.
2
Genetic Modulation of Lifespan: Dynamic Effects, Sex Differences, and Body Weight Trade-offs.寿命的基因调控:动态效应、性别差异及体重权衡
bioRxiv. 2025 Jul 21:2025.04.27.649857. doi: 10.1101/2025.04.27.649857.
3
Neuroprotective Effects of Metformin Through the Modulation of Neuroinflammation and Oxidative Stress.二甲双胍通过调节神经炎症和氧化应激发挥神经保护作用。

本文引用的文献

1
A triple drug combination targeting components of the nutrient-sensing network maximizes longevity.三药联合靶向营养感应网络组件可最大限度延长寿命。
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):20817-20819. doi: 10.1073/pnas.1913212116. Epub 2019 Sep 30.
2
Rapamycin protects aging muscle.雷帕霉素可保护衰老肌肉。
Aging (Albany NY). 2019 Aug 27;11(16):5868-5870. doi: 10.18632/aging.102176.
3
clinical trials for anti-aging therapies.抗衰老疗法的临床试验。
Cells. 2025 Jul 11;14(14):1064. doi: 10.3390/cells14141064.
4
PEG-Coated Ceria-Zirconia Nanoparticle Prevent Weight Gain and Obesity-Related Organ Damage Through Autophagy Flux Activation and ROS Scavenging.聚乙二醇包覆的二氧化铈-氧化锆纳米颗粒通过激活自噬通量和清除活性氧来预防体重增加和肥胖相关器官损伤。
Int J Nanomedicine. 2025 Jun 26;20:8305-8326. doi: 10.2147/IJN.S510541. eCollection 2025.
5
Calorie restriction mimetics against aging and inflammation.抗老化和抗炎的卡路里限制模拟物。
Biogerontology. 2025 Jun 24;26(4):126. doi: 10.1007/s10522-025-10269-0.
6
Branched-chain amino acid and cancer: metabolism, immune microenvironment and therapeutic targets.支链氨基酸与癌症:代谢、免疫微环境及治疗靶点
J Transl Med. 2025 Jun 10;23(1):636. doi: 10.1186/s12967-025-06664-3.
7
Metformin: An Old Drug with New Tricks-Promising Role in Vascular Aging and Cardioprotection.二甲双胍:一种有新用途的老药——在血管衰老和心脏保护方面的潜在作用
Drugs Aging. 2025 Jun 5. doi: 10.1007/s40266-025-01215-3.
8
Biological Effects of Dietary Restriction on Alzheimer's Disease: Experimental and Clinical Investigations.饮食限制对阿尔茨海默病的生物学效应:实验与临床研究
CNS Neurosci Ther. 2025 Apr;31(4):e70392. doi: 10.1111/cns.70392.
9
Interplay between ALK2 mutant receptor and autophagy signaling regulates receptor stability and its chondrogenic functions.ALK2 突变受体与自噬信号之间的相互作用调节受体稳定性及其软骨形成功能。
Cell Death Discov. 2025 Mar 22;11(1):117. doi: 10.1038/s41420-025-02393-0.
10
Exploration of the mechanism and therapy of ovarian aging by targeting cellular senescence.通过靶向细胞衰老探索卵巢衰老的机制及治疗方法。
Life Med. 2025 Jan 23;4(1):lnaf004. doi: 10.1093/lifemedi/lnaf004. eCollection 2025 Feb.
Aging (Albany NY). 2019 Aug 24;11(16):6591-6601. doi: 10.18632/aging.102180.
4
Fasting and rapamycin: diabetes versus benevolent glucose intolerance.禁食和雷帕霉素:糖尿病与良性葡萄糖耐量受损。
Cell Death Dis. 2019 Aug 13;10(8):607. doi: 10.1038/s41419-019-1822-8.
5
The mystery of the ketogenic diet: benevolent pseudo-diabetes.生酮饮食的奥秘:良性假糖尿病。
Cell Cycle. 2019 Sep;18(18):2157-2163. doi: 10.1080/15384101.2019.1644765. Epub 2019 Aug 1.
6
Partial Inhibition of mTORC1 in Aged Rats Counteracts the Decline in Muscle Mass and Reverses Molecular Signaling Associated with Sarcopenia.在老年大鼠中部分抑制 mTORC1 可逆转与肌肉减少症相关的肌肉质量下降和分子信号。
Mol Cell Biol. 2019 Sep 11;39(19). doi: 10.1128/MCB.00141-19. Print 2019 Oct 1.
7
mTOR and Aging: An Old Fashioned Dress.mTOR 与衰老:复古的装扮。
Int J Mol Sci. 2019 Jun 6;20(11):2774. doi: 10.3390/ijms20112774.
8
Rapamycin and Alzheimer disease: a double-edged sword?雷帕霉素与阿尔茨海默病:一把双刃剑?
Autophagy. 2019 Aug;15(8):1460-1462. doi: 10.1080/15548627.2019.1615823. Epub 2019 May 22.
9
The clinical course and potential underlying mechanisms of everolimus-induced hyperglycemia.依维莫司致高血糖的临床病程及潜在作用机制。
Endocr J. 2019 Jul 28;66(7):615-620. doi: 10.1507/endocrj.EJ18-0542. Epub 2019 Apr 13.
10
mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism.mTORC1通过诱导氧化应激和分解代谢导致与年龄相关的肌纤维损伤和丧失。
Aging Cell. 2019 Jun;18(3):e12943. doi: 10.1111/acel.12943. Epub 2019 Mar 29.